Combinatorial inhibition of focal adhesion kinase and BCL-2 enhances anti-leukemia activity of venetoclax in acute myeloid leukemia

Focal adhesion kinase (FAK) promotes cancer cell growth and metastasis. We previously reported that FAK inhibition by the selective inhibitor VS-4718 exerted anti-leukemia activities in AML. The mechanisms involved, and whether VS-4718 potentiates efficacy of other therapeutic agents, have not been...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Cancer Ther
Päätekijät: Wang, Xiangmeng, Mak, Po Yee, Mu, Hong, Tao, Wenjing, Rao, Arvind, Visweswaran, Ravikumar, Ruvolo, Vivian, Pachter, Jonathan A., Weaver, David T., Andreeff, Michael, Xu, Bing, Carter, Bing Z.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7416436/
https://ncbi.nlm.nih.gov/pubmed/32404407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-19-0841
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia